The Fort Worth Press - 'Whole family cried': New gene therapy offers hope for deaf kids

USD -
AED 3.672504
AFN 64.503991
ALL 81.720038
AMD 360.406323
ANG 1.790403
AOA 918.000367
ARS 1568.130552
AUD 1.4997
AWG 1.8025
AZN 1.70397
BAM 1.781807
BBD 2.01075
BDT 124.174373
BGN 1.77347
BHD 0.376714
BIF 3006.969435
BMD 1
BND 1.287933
BOB 11.65581
BRL 5.949504
BSD 0.998315
BTN 92.467544
BWP 14.234045
BYN 2.99713
BYR 19600
BZD 2.007835
CAD 1.43465
CDF 2280.000362
CHF 0.840443
CLF 0.025921
CLP 1017.646791
CNY 6.67775
CNH 6.682804
COP 3427.686421
CRC 446.863754
CUC 1
CUP 23.960279
CVE 100.455519
CZK 22.299704
DJF 177.779802
DKK 6.814905
DOP 60.22867
DZD 136.148135
EGP 53.415023
ERN 15
ETB 163.858971
EUR 0.91135
FJD 2.29155
FKP 0.763139
GBP 0.764526
GEL 2.603861
GGP 0.763139
GHS 11.755113
GIP 0.763139
GMD 74.000355
GNF 8850.726552
GTQ 7.630848
GYD 208.864392
HKD 7.83895
HNL 26.834601
HRK 6.831965
HTG 130.916048
HUF 340.290388
IDR 18292.95
ILS 3.34105
IMP 0.763139
INR 92.680504
IQD 1513.506127
IRR 1937364.503816
ISK 125.110386
JEP 0.763139
JMD 158.14695
JOD 0.70904
JPY 158.55504
KES 129.831914
KGS 87.450384
KHR 4073.247392
KMF 449.00035
KPW 900.00035
KRW 1346.160383
KWD 0.31178
KYD 0.831959
KZT 455.400173
LAK 22505.352344
LBP 89404.637179
LKR 332.009293
LRD 167.220881
LSL 17.451373
LTL 2.95274
LVL 0.60489
LYD 6.459254
MAD 9.983601
MDL 18.299094
MGA 4524.210814
MKD 56.078896
MMK 2100.158384
MNT 3607.934465
MOP 8.060128
MRU 40.693299
MUR 46.780378
MVR 15.403739
MWK 1731.152918
MXN 19.15845
MYR 4.113039
MZN 63.903729
NAD 17.451373
NGN 1355.000344
NIO 36.742131
NOK 9.76155
NPR 147.947889
NZD 1.828655
OMR 0.381679
PAB 0.998315
PEN 3.426958
PGK 4.494147
PHP 64.018038
PKR 275.965381
PLN 4.06445
PYG 6295.267162
QAR 3.649342
RON 4.877804
RSD 107.165308
RUB 81.477338
RWF 1474.878149
SAR 3.751806
SBD 8.124013
SCR 13.994038
SDG 601.503676
SEK 10.228904
SGD 1.289404
SHP 0.764263
SLE 22.850371
SLL 20969.503664
SOS 570.582608
SRD 37.363504
STD 20697.981008
STN 22.320412
SVC 8.735025
SYP 13002.000337
SZL 17.447274
THB 34.045038
TJS 9.179702
TMT 3.5
TND 3.023915
TOP 2.40776
TRY 50.538804
TTD 6.776295
TWD 32.969604
TZS 2663.052886
UAH 44.835512
UGX 4218.102309
UYU 40.595818
UZS 11951.897235
VES 917.61775
VND 25801.5
VUV 121.520976
WST 2.823319
XAF 597.806686
XAG 0.024398
XAU 0.00028370404
XCD 2.70255
XCG 1.799299
XDR 0.707052
XOF 597.806686
XPF 108.650298
YER 236.603589
ZAR 17.61858
ZMK 9001.203584
ZMW 20.555733
ZWL 321.999592
SSP 5776.450358
MXV 2.147601
  • RIO

    -0.3300

    97.04

    -0.34%

  • CMSC

    -0.0400

    20.67

    -0.19%

  • RELX

    0.0000

    33.41

    0%

  • RBGPF

    0.0000

    67.95

    0%

  • BCE

    -0.0700

    21.99

    -0.32%

  • BCC

    -0.0300

    75.66

    -0.04%

  • GSK

    0.8600

    51.08

    +1.68%

  • JRI

    -0.0300

    11.52

    -0.26%

  • NGG

    -0.1200

    76.68

    -0.16%

  • CMSD

    0.0900

    20.54

    +0.44%

  • BTI

    -0.0800

    55.75

    -0.14%

  • AZN

    2.0200

    168.1

    +1.2%

  • BP

    -1.4200

    43.16

    -3.29%

  • RYCEF

    0.4600

    19.7

    +2.34%

  • VOD

    0.0700

    17.02

    +0.41%

'Whole family cried': New gene therapy offers hope for deaf kids
'Whole family cried': New gene therapy offers hope for deaf kids / Photo: © Eye & Ent Hospital of Fudan University/AFP

'Whole family cried': New gene therapy offers hope for deaf kids

Zhu Yangyang babbles away like a typical happy three-year-old, calling out for "mama" and "papa" and accurately naming colors -- a remarkable achievement considering he was completely deaf just months ago.

Text size:

He is one of five children whose hearing was restored through a revolutionary new gene therapy in a clinical trial led by Chinese and American researchers, offering new hope for those born with a rare genetic mutation.

Yangyang's mother Chang Yiyi says she was moved to tears when she realized, around three weeks after the treatment last September, that Yangyang could hear her knocking on the door.

"I hid in a closet and called for him, and he still responded!" she told AFP in an interview from Shanghai.

The results of the study, published Wednesday in the prestigious journal Nature Medicine, mark the first time the procedure was performed on both ears. This led to significant improvements in speech perception and the ability to locate the source of sounds compared to treatment in just one ear.

"This is absolutely a turning point," Zheng-Yi Chen, the study's senior author at the Eaton-Peabody Laboratories at Mass Eye and Ear, told AFP, adding companies are now conducting clinical trials, including two in Boston, with the goal of moving towards regulatory approval.

"If the results hold, without any complications, I think in three to five years, it may be a medically approved product," he added.

- Rare mutation -

There are around 26 million people globally with genetic forms of deafness, with this particular therapy focusing on people born with a mutation of the OTOF gene -- roughly two to eight percent of inherited deafness cases.

This defect means they are unable to produce the protein otoferlin, which is needed for hair cells in the inner ear to convert sound vibrations into electrical signals that can be sent to the brain.

The treatment involves injecting a modified virus into the inner ear that smuggles in a working version of the OTOF gene, restoring hearing.

When they realized that Yangyang could hear for the first time, "the whole family cried" including Yangyang's mother and grandmother, said lead study author Yilai Shu of the Eye & ENT Hospital of Fudan University in Shanghai.

Chang, a 26-year-old homemaker, said that taking care of her son has become much easier since he began developing language skills, and the family soon hopes to move him from a speech rehabilitation school to traditional kindergarten.

- More genetic targets -

Shu led the research team that delivered the very first OTOF gene therapy in 2022, pioneering a treatment that has since been administered to more children around the world, including in the United States and the United Kingdom.

Treating both ears presented new challenges, he told AFP. Doubling the surgical procedures increased the risk of side effects.

However, careful dosing minimized the immune response, and only mild to moderate side effects -- like fever, vomiting and slightly elevated white cell counts -- were observed.

All five children, who ranged in age from one to 11, saw major improvements.

Two of them gained an ability to appreciate music -- a more complex acoustic signal -- and danced happily in videos recorded for the study.

Surprisingly, even the 11-year-old has gained some capacity to understand speech and talk, even though it was expected it would be too late for the brain to acquire this ability if it had never before perceived sound.

"That really shows our brain has a plasticity that maybe lasts much longer than we originally thought," said Chen. The clinical trial is ongoing, and the participants will be monitored for long-term follow up.

Meanwhile, Shu and Chen said they are working on further animal testing to develop treatments for other causes of genetic deafness, including those related to the GJB2 gene -- the most common cause of deafness present at birth.

D.Ford--TFWP